跳转到内容

RPMI-8226

添加链接
维基百科，自由的百科全书

RPMI-8226细胞是的一种人类多发性骨髓瘤永生细胞系，来源于一位61岁男性患者[1]，列入NCI-60[2]和LL-100[3]细胞列表广泛应用于生物学和癌症研究。

参考文献

  1. ^ Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.. Proceedings of the Society for Experimental Biology and Medicine. August 1967, 125 (4): 1246–50. PMID 6042436. S2CID 9643262. doi:10.3181/00379727-125-32327. 
  2. ^ NCI-60 Human Tumor Cell Lines Screen | Discovery & Development Services | Developmental Therapeutics Program (DTP). dtp.cancer.gov. [2024-02-12]. （原始内容存档于2023-09-24）. 
  3. ^ Quentmeier, H; Pommerenke, C; Dirks, WG; Eberth, S; Koeppel, M; MacLeod, RAF; Nagel, S; Steube, K; Uphoff, CC; Drexler, HG. The LL-100 panel: 100 cell lines for blood cancer studies.. Scientific Reports. 3 June 2019, 9 (1): 8218. Bibcode:2019NatSR...9.8218Q. PMC 6547646 可免费查阅. PMID 31160637. doi:10.1038/s41598-019-44491-x. 

外部链接

检索自“https://zh.wikipedia.org/w/index.php?title=RPMI-8226&oldid=83016962”